| Unique ID issued by UMIN | UMIN000059650 |
|---|---|
| Receipt number | R000067518 |
| Scientific Title | A Study on the Efficacy of Bridge Dry Swallowing for Gastroesophageal Reflux Disease: Randomised controlled trial |
| Date of disclosure of the study information | 2025/11/05 |
| Last modified on | 2025/11/05 17:24:37 |
A Study on the Efficacy of Bridge Dry Swallowing for Gastroesophageal Reflux Disease
Bridge Dry Swallowing for Gastroesophageal Reflux Disease
A Study on the Efficacy of Bridge Dry Swallowing for Gastroesophageal Reflux Disease: Randomised controlled trial
BRIDGE Trial
| Japan |
Gastroesophageal reflux
| Gastroenterology | Rehabilitation medicine |
Others
NO
The objective of this study is to evaluate whether a defined period of bridge dry swallowing training, performed in an anti-gravity (hip-raised) position, leads to improvement of symptoms in patients with mild gastroesophageal reflux disease (GERD).
Efficacy
FSSG (Frequency Scale for the Symptoms of GERD) questionnaire at 4-week follow-up
Upper Gastrointestinal Endoscopy
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
| Maneuver |
In addition to lifestyle guidance, participants will perform dry swallowing in the anti-gravity esophageal position (bridge position) 10 times per day for 4 weeks.
Lifestyle guidance
| Not applicable |
| Not applicable |
Male and Female
Patients with GERD symptoms and an FSSG (Frequency Scale for the Symptoms of GERD) score of more than 8.
Outpatients or inpatients in whom diseases other than GERD have been ruled out by EGD (esophagogastroduodenoscopy).
Patients with preserved cognitive function sufficient to fully understand the study outline and training procedure.
Patients who have provided written informed consent.
Patients who have difficulty assuming the bridge (hip-raised) position due to low back pain or other conditions.
Patients with severe dysphagia who are unable to swallow saliva.
Pregnant women or those who may be pregnant.
Patients with Los Angeles classification grade C or D esophagitis.
Patients taking acid-suppressing medications (PPI, P-CAB, H2-receptor antagonists), mosapride, rikkunshito, or aluminum hydroxide gel at the time of consent.
Patients with severe hiatal hernia who are considered to be at high risk of aspiration pneumonia due to regurgitation or vomiting.
Any other patients deemed inappropriate for inclusion by the principal investigator or subinvestigators.
48
| 1st name | Kei |
| Middle name | |
| Last name | Aoyama |
Chikamori Rehabilitation Hospital
Rehabilitation Medicine
780-0843
2-22, Nijudaimachi, Kochi-shi, Kochi 780-0843, Japan
088-822-5231
keiaoyama1209@yahoo.co.jp
| 1st name | Kenjiro |
| Middle name | |
| Last name | Kunieda |
Gifu University, Graduate School of Medicine
Department of Neurology
501-1194
1-1, Yanagido, Gifu-shi, Gifu
0582306254
ken2rou.k@gmail.com
Gifu University
Kenjiro Kunieda
Japan Science and Technology Agency
Japanese Governmental office
Japan
Department of Neurology, Graduate School of Medicine
1-1, Yanagido, Gifu-City, Gifu
0582306254
ken2rou.k@gmail.com
NO
岐阜県
| 2025 | Year | 11 | Month | 05 | Day |
Unpublished
Open public recruiting
| 2024 | Year | 12 | Month | 13 | Day |
| 2024 | Year | 12 | Month | 16 | Day |
| 2025 | Year | 01 | Month | 01 | Day |
| 2028 | Year | 08 | Month | 31 | Day |
| 2025 | Year | 11 | Month | 05 | Day |
| 2025 | Year | 11 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000067518